Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2012
03/08/2012WO2011146518A3 Pegylated c-peptide
03/08/2012WO2011143187A3 Lactoferrin -based biomaterials for tissue regeneration and drug delivery
03/08/2012WO2011139881A3 Compositions containing purine and pyrimidine nucleosides, peptides, and manganese and their uses
03/08/2012WO2011132955A3 Use of hades as tumor suppressor target
03/08/2012WO2011132943A3 Composition for treatment of acute pseudomembranous colitis
03/08/2012WO2011130537A3 Pharmaceutical compositions and methods for digesting atherosclerotic plaques
03/08/2012WO2011130479A3 Application of polymeric materials to screens to facilitate hemostasis and wound healing
03/08/2012WO2011127482A3 Modulation of histone deacetylases for the treatment of metabolic disease, methods and compositions related thereto
03/08/2012WO2011123179A3 Alkylated sp-c peptoid compounds and related surfactant compositions
03/08/2012WO2011122923A3 Long-acting interferon beta formulation using immunoglobulin fragment
03/08/2012WO2011122921A3 An insulin conjugate using an immunoglobulin fragment
03/08/2012WO2011116138A3 Peptide antimicrobials
03/08/2012WO2011096756A9 Pharmaceutical composition for inhibiting abnormal proliferation of cells
03/08/2012WO2011083482A3 Method for treatment of psoriasis
03/08/2012WO2011009042A8 Antigen compositions and methods of inhibiting campylobacter jejuni bacterial infection and uses of the antigen compositions
03/08/2012WO2011008548A8 Vaccines and compositions against streptococcus pneumoniae
03/08/2012WO2005123106A9 Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester to treat sunburn and other burns
03/08/2012WO2001000832A9 Methods for making apo-2 ligand using divalent metal ions
03/08/2012US20120059462 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
03/08/2012US20120059358 Dna vaccines encoding heat shock proteins
03/08/2012US20120059150 Methods for the production of apolipoproteins in transgenic plants
03/08/2012US20120059148 Non-naturally occurring lipoprotein particle
03/08/2012US20120059145 Stabilized bioactive peptides and methods of identification, synthesis, and use
03/08/2012US20120059049 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
03/08/2012US20120059047 Differentiation modulating agents and uses therefor
03/08/2012US20120058979 Methods and reagents for the treatment of immunoinflammatory disorders
03/08/2012US20120058958 Small Peptides And Methods For Blocking IgE Mediated Activation Of An Immune Cell
03/08/2012US20120058957 Compositions and methods for counteracting effects of reactive oxygen species and free radicals
03/08/2012US20120058956 Peptides derived from ficolin as surfactants
03/08/2012US20120058955 Use of decorine for increasing muscle mass
03/08/2012US20120058954 Diaza Heterocyclic Compounds for Phototherapy
03/08/2012US20120058953 Compositions and methods for enhancing apoptosis
03/08/2012US20120058952 Hmg-coa reductase derived peptide and cosmetic or pharmaceutical composition containing same
03/08/2012US20120058951 Neurotensin receptor agonists and opioid receptor agonists
03/08/2012US20120058950 Detection of neuropeptides associated with pelvic pain disorders and uses thereof
03/08/2012US20120058949 Methods of Treating Neurological Disorders
03/08/2012US20120058948 Collagen peptides as immune modulators
03/08/2012US20120058947 Prophylactic agent for heart failure
03/08/2012US20120058946 Compound and method for treating myotonic dystrophy
03/08/2012US20120058945 Neuroprotective iron chelators and pharmaceutical compositions comprising them
03/08/2012US20120058944 Bone morphogenetic protein 2 (bmp2) variants with reduced bmp antagonist sensitivity
03/08/2012US20120058943 Bioactive Hydrogel
03/08/2012US20120058942 Methods for controlling blood-glucose levels in insulin-requiring subjects
03/08/2012US20120058941 Glucopyranoside compound
03/08/2012US20120058940 Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
03/08/2012US20120058939 Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
03/08/2012US20120058938 Nutritional composition inducing a postprandial endocrine response
03/08/2012US20120058937 Prodrugs of Neuraminidase Inhibitors
03/08/2012US20120058936 Compositions and methods for elimination of gram negative bacteria
03/08/2012US20120058935 Antimicrobial compositions and methods of use therefore
03/08/2012US20120058934 Treatment of diseases
03/08/2012US20120058933 Synthetic peptides and peptide mimetics
03/08/2012US20120058932 Active ingredient-peptide construct for extracellular concentration
03/08/2012US20120058931 Drug target that promotes secretory granule-granule fusion
03/08/2012US20120058895 Compositions and methods for controlling pests with glycolipids
03/08/2012US20120058204 Use of over expression of cystathionine gamma lyase as a prognostic, diagnostic and therapeutic target for cancer
03/08/2012US20120058190 Food containing prolactin
03/08/2012US20120058187 Water-in-oil type emulsion for treating a disease of the eye
03/08/2012US20120058180 Liver-specific Nanocapsules and Methods of Using
03/08/2012US20120058174 Fabrication of interconnected model vasculature
03/08/2012US20120058172 Plant extracts for use in brain modulation
03/08/2012US20120058143 Staphylococcus aureus proteins and nucleic acids
03/08/2012US20120058137 Efficient transport into white blood cells
03/08/2012US20120058136 NON-SPLICING VARIANTS OF gp350/220
03/08/2012US20120058132 Treatment of glycogen storage disease type II
03/08/2012US20120058128 Anti- integrin antibodies, compositions, methods and uses
03/08/2012US20120058127 PAR2 Agonists for Use in the Treatment or Prevention of Influenza Virus Type A Infections
03/08/2012US20120058125 Methods relating to peripheral administration of nogo receptor polypeptides
03/08/2012US20120058120 Targets for Growth Factor Signalling and Methods of Therapy
03/08/2012US20120058119 Human tumor necrosis factor tr21 and methods based thereon
03/08/2012US20120058117 Neuropilin-1 inhibitors
03/08/2012US20120058115 method for promoting bone growth using activin-actriia antagonists
03/08/2012US20120058109 Reelin rescues cognitive function
03/08/2012US20120058107 Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors
03/08/2012US20120058106 Novel cancer-associated antigen
03/08/2012US20120058105 Method of treatment of vascular complications
03/08/2012US20120058103 Composition of individual proteolytic enzymes
03/08/2012US20120058102 Pharmacologically induced transgene ablation system
03/08/2012US20120058101 Treatment of human or animal body surface infection
03/08/2012US20120058100 Modulation of drug release rate from electrospun fibers
03/08/2012US20120058099 Use of hypoxanthine for promotion of neuronal outgrowth
03/08/2012US20120058098 Non-cytotoxic protein conjugates
03/08/2012US20120058092 Process for the preparation of a composition of genetically modified hematopoietic progenitor cells
03/08/2012US20120058090 Alimentary Protein-Based Scaffolds (APS) for Wound Healing, Regenerative Medicine and Drug Discovery
03/08/2012US20120058087 Diagnosis of endometritis
03/08/2012US20120058086 Compositions, kits, and methods for promoting ischemic and diabetic wound healing
03/08/2012US20120058085 Deuterium Modified Benzimidazoles
03/08/2012US20120058084 Interferon Alpha Carrier Prodrugs
03/08/2012US20120058083 Therapies for Chronic Inflammatory Demyelinating Polyneuropathy Using Interferon-Beta
03/08/2012US20120058082 Methods and compositions for treatment
03/08/2012US20120058081 Ex-vivo treatment of peripheral blood leukocytes with IFN-lambda
03/08/2012US20120058080 7-Nitro-2-(3-nitro phenyl)-4H-3,1-benzoxazin-4-one or derivatives thereof for treating or preventing antiviral infections
03/08/2012US20120058079 1,2,5-Oxadiazoles as Inhibitors of Indoleamine 2,3-Dioxygenase
03/08/2012US20120058078 Assay for the detection of factors that modulate the expression of ingap
03/08/2012US20120058075 Novel methods for cleaning a surface
03/08/2012US20120058066 Self-assembling peptide and peptide gel with high strength
03/08/2012DE102010040153A1 Stoffkombination zur Behandlung von entzündlichen oder infektiösen Erkrankungen Material combination for the treatment of inflammatory or infectious diseases
03/08/2012CA2810202A1 Methods and compositions for delivering interleukin-1 receptor antagonist
03/08/2012CA2809900A1 Use of interleukin-22 in treating viral hepatitis
03/08/2012CA2809774A1 Agonists of neurotrophin receptors and their use as medicaments
1 ... 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 ... 3163